Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

ORL 2010;72:295–299

A Comparison of the Short-Term Outcome in Patients with Acute Low-Tone Sensorineural Hearing Loss

Morita S. · Suzuki M. · Iizuka K.

Author affiliations

Department of Otolaryngology, Kushiro City General Hospital, Kushiro, Japan

Corresponding Author

Shinya Morita

Department of Otolaryngology

Kushiro City General Hospital

1-12 Shunkodai, Kushiro, Hokkaido 085-0822 (Japan)

Tel. +81 154 41 6121, Fax +81 154 41 4080, E-Mail shinyamorita@yahoo.co.jp

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Purpose of the Study: We aimed to compare the short-term outcome of patients with acute low-tone sensorineural hearing loss (ALHL) treated with steroid alone, diuretics alone or combination treatment. Procedures: Between April 2000 and March 2009, we retrospectively reviewed the medical records of 156 patients with a diagnosis of ALHL. All patients were followed up until improvement or for 8 weeks from the initial examination. Patients were treated with steroid alone (n = 49), diuretics alone (n = 40), combination treatment (n = 46) or they received neither steroid nor diuretics (n = 21). Results: The steroid-diuretic combination therapy for ALHL showed significantly better results than the steroid or diuretic treatments alone (p < 0.05). There were no clinically significant differences in the outcome between the steroid- and diuretic-alone treatments. Conclusion and Message: The etiology of ALHL is described as both an endolymphatic hydrops and an autoimmunological mechanism so that, as expected, the steroid-diuretic combination therapy was more effective than the steroid or diuretic treatments alone.

© 2010 S. Karger AG, Basel


  1. Abe T: Acute sensorineural hearing loss in low tone frequencies. Otolaryngology (Tokyo) 1982;54:385–392.
  2. Imamura S, Nozawa I, Imamura M, Murakami Y: Clinical observations on acute low-tone sensorineural hearing loss: survey and analysis of 137 patients. Ann Otol Rhinol Laryngol 1997;106:746–750.
  3. Yamasoba T, Sugasawa M, Kikuchi S, Yagi M, Harada T: An electrocochleographic study of acute low-tone sensorineural hearing loss. Eur Arch Otorhinolaryngol 1993;250:418–422.
  4. Fuse T, Hayashi T, Oota N, Fukase S, Asano S, Kato T, Aoyagi M: Immunological responses in acute low-tone sensorineural hearing loss and Ménière’s disease. Acta Otolaryngol 2003;123:26–31.
  5. Fuse T, Aoyagi M, Funakubo T, Sakakibara A, Yoshida S: Short-term outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid. ORL J Otorhinolaryngol Relat Spec 2002;64:6–10.
  6. Nozawa I, Imamura S, Mizukoshi A, Honda H, Okamoto Y: Clinical study of acute low-tone sensorineural hearing loss: survey and analysis of glycerol test and orthostatic test. Ann Otol Rhinol Laryngol 2002;111:160–164.
  7. Tomiyama S: Endolymphatic hydrops induced by immune response of the endolymphatic sac: relation perilymph antibody levels. Ann Otol Rhinol Laryngol Suppl 1992;157:48–53.
  8. McCabe BF: Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585–590.
  9. Parnes LS, Sun AH, Freeman DJ: Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1–17.
  10. Ruckenstein MJ, Milburn M, Hu L: Strial dysfunction in the MRL-Faslpr mouse. Otolaryngol Head Neck Surg 1999;121:452–456.
  11. Lin DW, Trune DR: Breakdown of stria vascularis blood-labyrinth barrier in CH3/lpr autoimmune disease mice. Otolaryngol Head Neck Surg 1997;117:530–534.
  12. Gross ND, Kempton JB, Trune DR: Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice. Laryngoscope 2002;112:298–303.
  13. Chandrasekhar SS, Rubinstein RY, Kwartler JA, Gatz M, Connelly PE, Huang E, Baredes S: Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000;122:521–528.
  14. Shea JJ, Ge X: Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière’s disease. Otolaryngol Clin North Am 1996;29:353–358.
  15. Silverstein H, Choo D, Rosenberg SI, Kuhn J, Seidman M, Stein I: Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 1996;75:468–488.
  16. Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W: Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière’s-associated sudden sensorineural hearing loss. Otol Neurotol 2005;26:890–895.
  17. Arriaga MA, Goldmann S: Hearing results of intratympanic steroid treatment of endolymphatic hydrops. Laryngoscope 1998;108:1682–1685.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 15, 2010
Accepted: April 21, 2010
Published online: September 01, 2010

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 1

ISSN: 0301-1569 (Print)
eISSN: 1423-0275 (Online)

For additional information: https://www.karger.com/ORL